Nektar Therapeutics在关于差异化问题的背景下发布了其研究性特应性皮炎药物Rezpeg的更多数据Nektar Therapeutics Releases Additional Data on Investigational Atopic Dermatitis Drug Rezpeg Amid Questions About Differentiation

动脉网
Sep 19

by Mark Chiang由马克·蒋Share To分享到Nektar Therapeutics has released additional data on its investigational drug rezpeg, which is being developed as a treatment for atopic dermatitis. Analysts at William ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10